Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

The Global Non-Small Cell Lung Carcinoma (NSCLC) Market is on the brink of an extraordinary transformation, with market ...

At the 2024 USPOULTRY Live Production, Welfare, and Biosecurity Seminar, experts highlighted key strategies for maintaining poultry health amidst challenges such as highly pathogenic avian influenza ...

October 1, 2024–Celebrate the magnificence of horses during Horse Week 2024, an online film festival proudly presented by ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

Boehringer Ingelheim focuses on targeting the proteins involved in this process as a promising strategy for developing new cancer treatments. Credit: Tada Images/Shutterstock. Boehringer Ingelheim and ...

"We continue to pursue claims against Boehringer Ingelheim for its wrongdoing in exposing millions of people to a known carcinogen for over a decade. Our fight against Boehringer Ingelheim ...

German drugmaker is vying for a place in the obesity market Company hopes liver data will help it carve out a niche Boehringer Ingelheim GmbH is open to more dealmaking to build its obesity portfolio ...

Boehringer Ingelheim has joined the competition to steal ... on patent expiry in Europe late next year, and in 2022 in the US. Currently the world’s biggest selling drug, Gonzalez has predicted ...